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Abstract Allele frequencies and forensically relevant popu-
lation statistics of 16 STR loci, including the new European
Standard Set (ESS) loci, were estimated from 668 unrelated
individuals of Caucasian appearance living in different parts
of Switzerland. The samples were amplified with a combina-
tion of the following three kits: AmpFlSTR® NGM SElect™,
PowerPlex® ESI17 and PowerPlex® ESX 17. All loci were
highly polymorphic and no significant departure from Hardy–
Weinberg equilibrium and linkage equilibrium was detected
after correction for sampling.
Keywords DNA .Multiplex STR . Forensic . Switzerland
Five Swiss laboratories, recognized by the Swiss Federal
Department of Justice and Police for performing DNA analy-
sis, have jointly decided to use a common local population
database for statistical calculations. All five laboratories are
accredited according to ISO/IEC 17025 and participate in
national and international (ex. GEDNAP) proficiency tests.
We determined the allelic proportions and forensic parameters
for 16 STR autosomal loci, including the five new European
Standard Set (ESS) loci [1], contained for instance in the
AmpFlSTR® NGM SElect™ (Applied Biosystems, USA)
and the PowerPlex® ESI 17/ESX 17 (Promega, USA) kits.
By publishing these data, our wish is to make them generally
available.
Blood samples or buccal cell swabs were collected, after
informed consent, from 668 unrelated individuals of
Caucasian appearance living in different parts of Switzerland
(Lausanne (n =200), Bern (n =202), Basel (n =21), Zurich
(n =202) and St. Gallen (n =43)). The samples from Zurich
and Lausanne were also used for European survey [2]. The
different regions with the exception of Lausanne (French
speaking) are all situated in the German-speaking part of the
country. All regions are geographically very close (less than
200 km).
The laboratories have used different DNA extractionmethods
including iPrep, NaOH, Chelex and phenol–chloroform.
The samples from Basel were amplified only with the
AmpFlSTR® NGM SElect™ kit. The two laboratories from
Bern and St. Gallen used a combination of the PowerPlex®
ESI17 and PowerPlex® ESX 17 kits. The samples from
Lausanne and Zurich were amplified using a combination of
all the three aforementioned kits. Samples were amplified
using 0.25–1.25 ng of target DNA using reaction conditions
as described by each manufacturer (occasionally, a reduced
PCR volume was used).
The amplified products were detected on the ABI PRISM
3100xl and 3130xl Genetic Analyzer (Applied Biosystems,
USA) sequencers. Allele calling was performed using
GeneMapper ID v3.2 (Applied Biosystems, USA) following
the recommendations of the DNA Commission of the
International Society of Forensic Genetics (IFSG) for the
nomenclature of human STRs [3, 4].
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For concordance studies, 245 samples (Bern and St.
Gallen) were typed each with PowerPlex® ESI 17 and
PowerPlex® ESX 17 and another 402 (Lausanne and
Zurich) were typed using the same three kits (PowerPlex®
ESI 17, PowerPlex® ESX 17 and AmpFlSTR® NGM
SElect™). A comparison of all results revealed no differences
between the genotypes obtained using the different kits.
Allelic proportions and forensic parameters were calculated
using PowerStats version 1.2 [5] (see Table 1). Fst values,
gene diversity and P values for Hardy–Weinberg equilibrium
were assessed using FSTAT (http://www.unil.ch/Jahia/site/
dee/op/edit/pid/36921).
The P value for Hardy–Weinberg proportions, when using
the Bonferroni correction, was assigned as P <0.05/15=
0.0033. As suggested by Buckleton et al. [6], we do not
comment on the value itself, indeed ‘It is not likely that
Hardy-Weinberg disequilibrium, at the level it is thought to
exist in human populations, will be detected with samples of
1000 or less’.
The observed heterozygosity varies between 0.741 for
D22S1045 and 0.948 for SE33. The gene diversity (also
termed Hex) was smallest for D22S1045 (0.732) and larg-
est for SE33 (0.948). The power of discrimination ranges
from 0.883 for D22S1045 to 0.993 for SE33. Before
pooling the data, we calculated coancestry values (Fst)
values for the 16 NGM SElect loci for the five Swiss
population groups reported here (Table 2). The maximum
Fst was observed at the D3S1358 locus (i.e. 0.003).
Altogether, based on these data and on the general knowl-
edge of the population substructure in Europe, we decided
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Table 2 Fst values
based on five Swiss
population samples
Fst
D3S1358 0.003
D19S433 −0.001
D2S1338 −0.001
D22S1045 0.000
D16S533 0.001
D18S51 0.000
D1S1656 0.000
D10S1248 0.001
D2S441 −0.001
TH01 −0.001
vWA −0.000
D21S11 −0.001
D12S391 −0.001
D8S1179 −0.002
FGA 0.001
SE33 0.000
Avg −0.000
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to group the allelic frequency data of the different Swiss
regions together in order to obtain national population
data.
Our samples from Zurich (n =202) and Lausanne (n =200)
were previously compared to 24 European populations [2].
This study showed that the genetic variability is evenly dis-
tributed among these populations. Regarding the value of
theta itself, we recommend to use the widely accepted value
of 0.01.
In conclusion, we believe that for cases where the relevant
population is Switzerland, these data will be useful; thus, our
wish is to make them available publicly. This paper follows
the guidelines for publication of population data requested by
the journal [7].
Finally, the authors would like to thankMrs Nathalie Hicks
Champod of the Faculty of Law and Criminal Justice in
Lausanne who reviewed this manuscript for her time, exper-
tise and useful suggestions and comments.
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